Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Uro-catheter Vacuum-induced Uterine Tamponade (U-CaVIT) Versus Standard of Care for Prevention of Atonic Postpartum Hemorrhage After Cesarean Section in High-risk Women: a Monocentric Randomized-controlled Pilot Study.

NCT07019623 is registered in ClinicalTrials.gov with Christian Haslinger as lead sponsor.

NCT NCT07019623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07019623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Uro-catheter Vacuum-induced Uterine Tamponade (U-CaVIT) Versus Standard of Care for Prevention of Atonic Postpartum Hemorrhage After Cesarean Section in High-risk Women: a Monocentric Randomized-controlled Pilot Study.
Lead sponsor
Christian Haslinger
Phase
Not applicable
Overall status
Recruiting
Start date
May 28, 2025
Completion date
November 30, 2026
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

balloon, cesarean delivery, delivery ,complications,maternal, hemorrhage, postpartum complication, postpartum hemorrhage (primary), pregnancy complications